id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-0931-0009,FDA,FDA-2022-E-0931,Requirement for Information,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T20:49:09Z,,0,0,090000648661359c
FDA-2022-E-0931-0008,FDA,FDA-2022-E-0931,Order Granting Interim Extension,Other,Letter(s),2024-07-31T04:00:00Z,2024,7,2024-07-31T04:00:00Z,,2024-07-31T12:36:48Z,,0,0,09000064866064cf
FDA-2022-E-0931-0006,FDA,FDA-2022-E-0931,Letter from FDA CDER to U. S. Patent and Trademark Office,Other,Letter(s),2024-01-19T05:00:00Z,2024,1,2024-01-19T05:00:00Z,,2024-01-19T21:47:56Z,,0,0,09000064863ae227